John Wallace
Chairman presso Antibe Holdings, Inc.
Patrimonio netto: 658 511 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Takashi Nagao | M | - |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | - |
| Daniel Legault | M | 66 |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The private company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | 19 anni |
| Martin Kolb | M | - |
McMaster University
| - |
| Juliet Daniel | F | - |
McMaster University
| - |
| Barry Nicol | M | - |
McMaster University
| - |
| David Huctwith | M | - |
McMaster University
| - |
| Christina Cameron | F | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | - |
| Arjun Kumar | M | - |
McMaster University
| - |
| John Manley | M | 74 |
McMaster University
| - |
| Michael Verbora | M | - |
McMaster University
| 6 anni |
| Khaled Hassanein | M | - |
McMaster University
| - |
| Sonny Kohli | M | - |
McMaster University
| 14 anni |
| James Macpherson | M | - |
McMaster University
| - |
| John Valliant | M | 54 |
McMaster University
| 25 anni |
| Natalia K. Nikolova | M | - |
McMaster University
| 25 anni |
| Matsuo Kikuchi | M | 64 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 8 anni |
| Michael Ferencich | M | - |
McMaster University
| - |
| Christina Bryce | F | - |
McMaster University
| - |
| Stephanie Baschiera | F | - |
McMaster University
| - |
| Marc Letendre | M | - |
McMaster University
| - |
| Jeanne Tan | F | - |
McMaster University
| - |
| Chris Sinding | M | - |
McMaster University
| - |
| Arlene Dosen | F | - |
McMaster University
| - |
| Jerry Hurley | M | - |
McMaster University
| - |
| Pamela Swett | F | - |
McMaster University
| - |
| Karen Mossaman | F | - |
McMaster University
| - |
| Fiona McNeill | F | - |
McMaster University
| - |
| Joseph Gabriele | M | - |
McMaster University
| - |
| Judith Shedden | F | - |
McMaster University
| - |
| Sara Bannerman | F | - |
McMaster University
| - |
| Spencer Pope | M | - |
McMaster University
| - |
| Judy West-Mays | F | - |
McMaster University
| - |
| Sandeep Raha | M | - |
McMaster University
| - |
| Dean Mountain | M | - |
McMaster University
| - |
| To fart Luongo | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 anni |
| Jeffrey Weitz | M | - |
McMaster University
| - |
| Marion B. Lyver | M | - |
McMaster University
| - |
| Peter Horsewood | M | - |
McMaster University
| - |
| Fraser Reeve Berrill | M | 75 |
McMaster University
| - |
| H. Barber | M | - |
McMaster University
| - |
| Jim A. Wright | M | - |
McMaster University
| 14 anni |
| Rocco Taglioni | M | - |
McMaster University
| - |
| Kevin P. D. Smith | M | 61 |
McMaster University
| - |
| Richard Rossman | M | - |
McMaster University
| - |
| Paul D. Campbell | M | 76 |
McMaster University
| - |
| James B. Mahony | M | - |
McMaster University
| - |
| Emõke J. E. Szathmáry | M | 81 |
McMaster University
| - |
| James Paul | M | - |
McMaster University
| - |
| Robert G. Cooper | M | - |
McMaster University
| - |
| John Bienenstock | M | 87 |
McMaster University
| - |
| Ronald Campbell Loucks | M | - |
McMaster University
| - |
| Mary Maher | F | 63 |
McMaster University
| - |
| Grant B. Walsh | M | 75 |
McMaster University
| - |
| Lynton R. Wilson | M | 84 |
McMaster University
| - |
| Yoshihisa Sasou | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 anni |
| Michael T. Newhouse | M | - |
McMaster University
| - |
| Marc-André D'Aoust | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 25 anni |
| David Vaughan | M | 74 |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The private company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | 17 anni |
| John C. Luxat | M | - |
McMaster University
| - |
| Woo-Young Kim | M | - |
McMaster University
| 13 anni |
| Seiichi Murakami | M | 67 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 anni |
| Connie A. Stefankiewicz | F | - |
McMaster University
| - |
| Mark Larché | M | - |
McMaster University
| - |
| Gary Kain | M | - |
McMaster University
| - |
| Marc Kealey | M | - |
McMaster University
| - |
| Paul Dixon Allison | M | - |
McMaster University
| - |
| Yaser M. Haddara | M | - |
McMaster University
| - |
| Emechete Onuoha | M | - |
McMaster University
| - |
| Roger Couldrey | M | - |
McMaster University
| - |
| S. R. Rafael Jose Faucher | M | - |
McMaster University
| - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 70 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John Wallace
- Contatti personali
